AGRANULOCYTOSIS / NEUTROPENIA
See full prescribing information for complete boxed warning.
- Trade Name: Ferriprox (ApoPharma)
- Indications: Treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate
- Class: Chelator, iron
- Half-life: 1.9 hours
- Clinically important, potentially hazardous interactions with:
Antacids containing iron, aluminum, zinc, Diclofenac, Mineral supplements, Probenecid
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
